Fortrea (FTRE)
Runs clinical trials and development services for drug, biotech, and device sponsors.
$20.19
vs last close−0.24 (−1.17%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 107.73% | 102.45M shares | |
|---|---|---|---|
| 338 holders · as of Jun 30, 2026 | |||
| Insiders | 1.13% | 1.07M shares | |
| 15 holders · as of Sep 10, 2026 | |||
| Adds to | 108.86% | ||
95.10M company shares as of Sep 1, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
These groups come from separate filings that can overlap, so they add to 108.86%; nothing is left for Other.
13F, as of Jun 30, 2026
338 holders · 102.45M shares · 46 new positions · 143 increased · 110 reduced · 43 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 15.80M | 16.61% | +646.7K | Aug 7, 2026 |
| Goldman Sachs Group Inc | 8.41M | 8.85% | +315.5K | Aug 14, 2026 |
| Sessa Capital Im, L.P. | 4.59M | 4.83% | 0 | Aug 14, 2026 |
| Vanguard Capital Management LLC | 4.18M | 4.40% | +143.0K | Aug 13, 2026 |
| Vanguard Portfolio Management LLC | 3.82M | 4.01% | +119.9K | Aug 13, 2026 |
| State Street Corp | 3.78M | 3.98% | −325.2K | Aug 7, 2026 |
| FMR LLC | 3.65M | 3.83% | +2.40M | Aug 13, 2026 |
| Corvex Management LP | 2.99M | 3.14% | −1.66M | Aug 14, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 15.30% | 13.81M | 13G | Jul 17, 2025 |
| The Goldman Sachs Group, Inc. | 8.90% | 8.03M | 13G | Aug 13, 2025 |
| Vanguard Capital Management | 5.05% | 4.73M | 13G | Apr 29, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Sep 9, 2026 | Carrie Elizabeth Russellofficer: Interim CAO | Sale | 246 | $16.85 | 2,384 |
| Sep 9, 2026 | Mark A. Moraisofficer: Chief Operating Officer | Sale | 3,149 | $16.85 | 81,794 |
| Aug 19, 2026 | Mark A. Moraisofficer: Chief Operating Officer | Sale | 4,892 | $18.19 | 77,786 |
| Aug 6, 2026 | Anshul Thakraldirector, officer: Chief Executive Officer | Sale · 2 lots | 111,857 | $18.11 | 204,940 |
| Aug 5, 2026 | Anshul Thakraldirector, officer: Chief Executive Officer | Sale · 2 lots | 99,869 | $19.16 | 316,797 |
| Aug 3, 2026 | Machelle Sandersdirector | Sale | 9,700 | $18.01 | 36,399 |
| Jun 10, 2026 | Mark A. Moraisofficer: Chief Operating Officer | Sale | 4,674 | $16.82 | 71,365 |
| May 18, 2026 | Robert Parksofficer: Chief Accounting Officer | Sale | 2,000 | $13.44 | 20,389 |
| Mar 16, 2026 | Jill G. Mcconnellofficer: Chief Financial Officer | Sale | 1,804 | $9.22 | 72,276 |
| Mar 16, 2026 | Mark A. Moraisofficer: Chief Operating Officer | Sale | 1,804 | $9.22 | 69,899 |
House and Senate disclosures
Not reported.